Tag: Vertebroplasty
VAPOUR trial results reinstate Medicare funding for vertebroplasty in Australia
Lead author of the VAPOUR trial (Vertebroplasty for Acute Painful Osteoporotic fractURes) William Clark discusses the recent history of Australian Medicare funding for vertebroplasty,...
Merit Medical launches Arcadia steerable and straight balloons
Merit Medical has announced the official market launch of its Arcadia steerable and straight balloons for vertebral augmentation. These balloons are designed to help...
Percutaneous vertebroplasty safe and effective only in patients with acute fractures
A meta-analysis, recently published in Osteoporosis International, has found that the application of percutaneous vertebroplasty (PVP) is safe and effective only in patients with...
Response: The ASBMR taskforce report is “dangerous” and “shameful”
A recent taskforce report charged by the American Society for Bone and Mineral Research (ASBMR) concluded that current evidence does not support the routine...
“No further trials of vertebroplasty should be performed”, report concludes
Current evidence does not support the use of vertebroplasty for the treatment of pain from vertebral fractures, concludes a recent task force report charged...
VERTOS IV raises doubts about vertebroplasty
Percutaneous vertebroplasty does not result in statistically significant greater pain relief than a sham procedure, reports a study detailing the results of the VERTOS...
VAPOUR trial produces robust new evidence for vertebroplasty
The VAPOUR trial proves that vertebroplasty is effective in patients with severe pain and fractures of less than six weeks’ duration, when an adequate...
Vertebroplasty trumps placebo in treatment of painful spinal fractures
On 17 August, a multicentre, randomised, double-blind, placebo-controlled trial—the VAPOUR trial—was published online ahead of print in The Lancet. Six-month data from the trial...
